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Dengue virus (DV) is a mosquito-borne pathogen capable
of infecting multiple target organs in the human host.
Infection with any one of the four dengue serotypes can
cause an acute febrile illness known as Dengue Fever (DF),
while subsequent infection with a heterologous serotype
or a highly virulent strain can result in the more severe
and sometimes lethal Dengue Hemorrhagic Fever (DHF)
and Dengue Shock Syndrome (DSS). According to the
World Health Organization, approximately 2.5 billion peo-
ple live in dengue endemic countries, with an estimated 50
million cases occurring annually. The lack of an effective
dengue vaccine has prompted the need to discover
compounds that can inhibit DV infection. In this study, a
cell-based, high-throughput assay system that utilizes an
image-based analysis algorithm for evaluating active com-
pounds that target DV infection is described. Using repre-
sentative strains of DV1, DV2, DV3 serotypes, a human-
derived hepatoma cell line (Huh7.5) and Aedes albopictus
mosquito-derived cell line (clone C6/36) were inoculated
with a high titer of each virus in a 384-well plate culture
system in the presence of varying concentration of known
active compounds. After 1-2 rounds of viral replication
(48~72 h), infection was arrested by para-formaldehyde
fixation. DV-infected cells were visualized by probing with
D1-4G2-4-15 mAb, a flavivirus group-specific monoclonal
antibody that targets the E protein, and a mouse IgG-
specific AlexaFluor488
TM secondary antibody. Images of
the DV-infected cell culture are captured with an
automated confocal microscope (Evotec Opera
TM), and
analyzed using IM v3.0, a custom-based image analysis
software developed by IP-Korea’s Image Mining Group. A
10-point dose-response curve was generated for each
active compound and reproduced in several experiments.
This newly developed HTA (High Throughput Assay)
system for Dengue can be a useful tool to screen large
compound libraries for active drugs that have inhibitory
effects to DV infection.
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